Viewing Study NCT00645034


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-03-02 @ 3:48 PM
Study NCT ID: NCT00645034
Status: COMPLETED
Last Update Posted: 2021-02-01
First Post: 2008-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A1481163
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators